Patents by Inventor Stephen J. Spatz

Stephen J. Spatz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECOMBINANT VACCINE AGAINST MAREK'S DISEASE AND NEWCASTLE DISEASE
    Publication number: 20220185848
    Abstract: Provided herein are immunogenic compositions containing recombinant viruses capable of inducing protection in poultry against both Marek's disease virus (MDV) and Newcastle disease virus (NDV). Such viruses incorporate nucleic acids for expressing at least one MDV antigen, such as glycoprotein B, and antigenic portions thereof, in a recombinant NDV genome.
    Type: Application
    Filed: February 28, 2022
    Publication date: June 16, 2022
    Inventors: QINGZHONG YU, STEPHEN J. SPATZ, JOHN R. DUNN
  • Recombinant vaccine against Marek's disease and Newcastle disease
    Patent number: 11299517
    Abstract: Provided herein are immunogenic compositions containing recombinant viruses capable of inducing protection in poultry against both Marek's disease virus (MDV) and Newcastle disease virus (NDV). Such viruses incorporate nucleic acids for expressing at least one MDV antigen, such as glycoprotein B, and antigenic portions thereof, in a recombinant NDV genome.
    Type: Grant
    Filed: April 15, 2020
    Date of Patent: April 12, 2022
    Assignee: The United States of America, as represented by The Secretary of Agriculture
    Inventors: Qingzhong Yu, Stephen J. Spatz, John R. Dunn
  • RECOMBINANT VACCINE AGAINST MAREK'S DISEASE AND NEWCASTLE DISEASE
    Publication number: 20210324016
    Abstract: Provided herein are immunogenic compositions containing recombinant viruses capable of inducing protection in poultry against both Marek's disease virus (MDV) and Newcastle disease virus (NDV). Such viruses incorporate nucleic acids for expressing at least one MDV antigen, such as glycoprotein B, and antigenic portions thereof, in a recombinant NDV genome.
    Type: Application
    Filed: April 15, 2020
    Publication date: October 21, 2021
    Inventors: QINGZHONG YU, STEPHEN J. SPATZ, JOHN R. DUNN
  • Immunogenic composition
    Patent number: 9950059
    Abstract: Recombinant chimeric viruses based on NDV LaSota strain and containing either ILTV gB or gD are produced. Administration of the chimeric viruses to chickens induces an immune response in the animal against both NDV and ILTV. Immunogenic compositions, plasmids, kits and methods are described.
    Type: Grant
    Filed: February 13, 2015
    Date of Patent: April 24, 2018
    Assignee: The United States of America, as represented by the Secretary of Agriculture.
    Inventors: Qingzhong Yu, Stephen J. Spatz, Laszlo Zsak
  • NOVEL IMMUNOGENIC COMPOSITION
    Publication number: 20170072046
    Abstract: Recombinant chimeric viruses based on NDV LaSota strain and containing either ILTV gB or gD are produced. Administration of the chimeric viruses to chickens induces an immune response in the animal against both NDV and ILTV. Immunogenic compositions, plasmids, kits and methods are described.
    Type: Application
    Filed: February 13, 2015
    Publication date: March 16, 2017
    Inventors: Qingzhong YU, Stephen J. SPATZ, Laszlo ZSAK
  • Recombinant poxvirus vaccine against feline rhinotracheitis
    Patent number: 6010703
    Abstract: A recombinant poxvirus vaccine against feline herpesvirus (FHV-1) is described. The recombinant poxviruses include synthetic genes encoding either a gB or gD precursor polypeptide or mixtures of the two recombinant poxviruses. The vaccine is used to provide immunity to FHV-1 in cats.
    Type: Grant
    Filed: August 14, 1997
    Date of Patent: January 4, 2000
    Assignee: Board of Trustees operating Michigan State University
    Inventors: Roger K. Maes, Stephen J. Spatz